Changeflow GovPing Healthcare & Life Sciences Lymphocyte Population and Methods for Producing...
Routine Rule Added Final

Lymphocyte Population and Methods for Producing Same

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4110902A1 titled "Lymphocyte Population and Methods for Producing Same" on April 15, 2026. The application, filed by AVM Biotechnology, LLC of the United States, names inventors Theresa Deisher and Scot Wayne McKay. The invention is classified under IPC codes C12N 5/0783 and A61K 31/573, covering lymphocyte populations and production methods. The application designates all contracting states under the European patent system.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 61 changes logged to date.

What changed

The European Patent Office published patent application EP4110902A1 for a lymphocyte population invention developed by AVM Biotechnology, LLC. The application names Theresa Deisher and Scot Wayne McKay as inventors and covers methods for producing lymphocyte populations classified under IPC codes C12N 5/0783 and A61K 31/573.

Pharmaceutical and biotechnology companies researching lymphocyte-based therapies or cell population expansion methods should review the published claims for potential licensing considerations or freedom-to-operate analysis. The publication of this application represents a public record of one competitor's intellectual property direction in the cell therapy space.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

LYPMPHOCYTE POPULATION AND METHODS FOR PRODUCING SAME

Publication EP4110902A1 Kind: A1 Apr 15, 2026

Applicants

AVM Biotechnology, LLC

Inventors

DEISHER, Theresa, MCKAY, Scot Wayne

IPC Classifications

C12N 5/0783 20100101AFI20210903BHEP A61K 31/573 20060101ALI20210903BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4110902A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent examination IP licensing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!